TocilizuMab discontinuAtion in GIant Cell Arteritis

NCT06037460 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Giant Cell Arteritis

Interventions

DRUG: Tocilizumab treatment
OTHER: questionnaires
BIOLOGICAL: Blood samples
PROCEDURE: 18FDG PET scan

Sponsor

Centre Hospitalier Universitaire Dijon